Table 1.
Summary of incidental cholangiocarcinoma histopathological findings.
| # | Authors Year Published |
Time of the Study | Number of Patients | Mean Number of Lesions | Mean Size of Lesion (cm) |
Number (and Percentage) of Tumor Recurrences |
Number (and Percentage) of Suspected Malignancies | Recurrence Time after Transplantation | Survival Time after Recurrence |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Loinaz C et al. [6] 1998 | 11 years 3 months | 2 | 1.2 | 1 | 1 (50%) | NR | NR | 58 months |
| 2 | Ghali P et al. [7] 2005 | 7 years | 10 | NR | NR | 10 (100%) Intrahepatic: 4, Extrahepatic: 6, site NR |
1 (10.0%) |
26 months, median | 30 months, median |
| 3 | Ali JM et al. [8] 2011 | 20 years | 9 | NR | 2.05 | 5 (55.56%) Sites: bone, lungs, small bowels, peritoneal |
3 (33.33%) |
25.8 months, median | 25 months |
| 4 | Sapisochin G et al. [9] 2011 | 10 years | 14 | 1 | 2.5 | 8 (57%) Intrahepatic: 1 Extrahepatic: 6, site NR Both: 1 |
10 (71.43%) |
8 moths, median | 9 months, median |
| 5 | Serra V et al. [10] 2016 | 15 years | 4 | NR | 3.33 | 3 (75%) Intrahepatic: 1 Extrahepatic: 2, sites: lungs, bones |
4 (100%) |
15, 49 months, mean | 24, 76 months, mean |
| 6 | Takashi K et al. [11] 2016 | 11 years | 13 | 1.9 | 2.1 | 7 (53.8%) Intrahepatic: 1 Extrahepatic: 6, site: lungs, intraperitoneal |
5 (38.46%) |
13 months, median | NR |
| 7 | Elshamy M et al. [12] 2017 | 10 years 11 months | 13 | 2.0 | 2.8 | 1 (30.8%), extrahepatic, site: lungs |
11 (84.62%) |
35.6 months, median | NR |
| 8 | Mitra S et al. [13] 2018 | - | 1 | 1 | NR | 0 | 0 (0%) |
- | - |
| 9 | Krasnodębski M et al. [14] 2020 | 24 years 8 months | 8 | NR | 3.8 | 6 (75.0%), sites NR | NR | 6 months, median | 18 months, median |
| 10 | Torres MAH et al. [15] 2020 | - | 1 | 2 | 4.3 | 0 | 1 (100%) |
- | - |
| 11 | Ziogas IA et al. [16] 2021 | 17 years 5 months | 286 | NR | NR | NR | NR | NR | NR |
| 12 | Murta MCB et al. [17] 2022 | - | 1 | 1 | 1.7 | 0 | 0 (0%) |
- | - |
| 13 | Safdar NZ et al. [18] 2022 | 32 years 7 months | 40 (other sites 55) | NR | NR | NR | NR | NR | NR |
| 14 | Garcia-Moreno V et al. [19] 2023 | 13 years 11 months | 7 | 1 | NR (largest nodule 2.2 cm) | 0 | 4 (57.14%) | - | - |
| 15 | Schwenk L et al. [20] 2023 | 4 | 1 | 3.125 | NR | 0 | NR | - | - |